Clinical Trial Update: Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases [Phase 1]

View source ↗

Summary

Phase 1 trial update on belinostat plus azacitidine in adults with advanced hematologic cancers. The study has completed enrollment and evaluated this combinati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Atypical Chronic Myeloid Leukemia
• Myelodysplastic Myeloproliferative Neoplasm Unclassifiable
• Myelodysplastic Syndrome
• Myelofibrosis
• Myelogenous Leukemia
• Myelomonocytic Leukemia

Drugs mentioned

• BELEODAQ (BELINOSTAT)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Accelerated Phase of Disease, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 | Phase 1 | Status: COMPLETED